Microbial Fermentation Technology Global Market Opportunities and Strategies to 2035

This report describes and explains the microbial fermentation technology market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global microbial fermentation technology market reached a value of nearly $40.76 billion in 2025, having grown at a compound annual growth rate (CAGR) of 7.1% since 2020. The market is expected to grow from $40.76 billion in 2025 to $55.43 billion in 2030 at a rate of 6.3%. The market is then expected to grow at a CAGR of 5.6% from 2030 and reach $72.85 billion in 2035.

Growth in the historic period resulted from rise in demand for personalized medicine, growing adoption in food and beverage, rising consumer demand for natural and organic food products and increasing demand for alternative proteins. Factors that negatively affected growth in the historic period were strict government regulations and risk of contamination during fermentation.

Going forward, expansion of chronic and infectious diseases, advancements in bioprocess automation, rising demand for biopharmaceuticals and expanding use of probiotics, postbiotics, and functional microbiome will drive the growth. Factor that could hinder the growth of the microbial fermentation technology market in the future include high production costs, difficulty in scaling up production and impact of trade war and tariff.

The microbial fermentation technology market is segmented by type into medical, industrial, alcohol beverages and food and feed products. The medical market was the largest segment of the microbial fermentation technology market segmented by type, accounting for 63.9% or $26.06 billion of the total in 2025. Going forward, the medical segment is expected to be the fastest-growing segment in the microbial fermentation technology market segmented by type, at a CAGR of 6.6% during 2025-2030.

The microbial fermentation technology market is segmented by end users into bio-pharmaceutical companies, contract research organizations (CROs), contract manufacturing organization (CMOs) and contract development and manufacturing organization (CDMOs), food and beverage manufacturers, industrial biotechnology companies and academic and research institutes. The bio-pharmaceutical companies market was the largest segment of the microbial fermentation technology market segmented by end users, accounting for 33.1% or $13.49 billion of the total in 2025. Going forward, the contract manufacturing organization (CMOs) and contract development and manufacturing organization (CDMOs) segment is expected to be the fastest-growing segment in the microbial fermentation technology market segmented by end users, at a CAGR of 8.3% during 2025-2030.

The microbial fermentation technology market is segmented by application into antibiotics, probiotics supplements, monoclonal antibodies, recombinant proteins, biosimilars, vaccines, enzymes and small molecules. The antibiotics market was the largest segment of the microbial fermentation technology market segmented by application, accounting for 31.3% or $12.74 billion of the total in 2025. Going forward, the biosimilars segment is expected to be the fastest-growing segment in the microbial fermentation technology market segmented by application, at a CAGR of 9.6% during 2025-2030.

Asia-Pacific was the largest region in the microbial fermentation technology market, accounting for 42.3% or $17.25 billion of the total in 2025. It was followed by North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the microbial fermentation technology market will be Asia-Pacific and Eastern Europe where growth will be at CAGRs of 8.2% and 6.2% respectively. These will be followed by Africa and Middle East where the markets are expected to grow at CAGRs of 6% and 5.7% respectively.

Market-trend-based strategies for the microbial fermentation technology market include focus on advancing precision fermentation systems that enable consistent production of key fermentation-derived components, focus on forming strategic collaborations and launching facilities to expand the production of functional food ingredients, focus on investing in and launching advanced pilot-scale fermentation technology centers to support the scale-up of sustainable alternative proteins and functional food ingredients and focus on establishing strategic collaborations and technology partnerships to advance sustainable bio-based chemical and enzyme production.

The global microbial fermentation technology market is highly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 4.06% of the total market in 2024. Novonesis (Novozymes A/S) was the largest competitor with a 1.63% share of the market, followed by Koninklijke DSM N.V. with 1.57%, Lonza Group AG with 1.46%, Cargill Inc. with 0.93%, Evonik Industries AG (Health & Care) with 0.90%, Ajinomoto Co Inc. with 0.69%, AGC Group with 0.61%, Amyris Inc. with 0.34%, Ginkgo Bioworks Inc. with 0.18% and Biovectra Inc. with 0.18%.

The top opportunities in the microbial fermentation technology markets segmented by type will arise in the medical segment, which will gain $9.83 billion of global annual sales by 2030. The top opportunities in the microbial fermentation technology markets segmented by application will arise in the antibiotics segment, which will gain $3.32 billion of global annual sales by 2030. The top opportunities in the microbial fermentation technology markets segmented by end users will arise in the bio-pharmaceutical companies segment, which will gain $4.69 billion of global annual sales by 2030. The microbial fermentation technology market size will gain the most in China at $4.53 billion.

Player-adopted strategies in the microbial fermentation technology market focus on strengthening its operational capabilities through new product launches and focus on strengthening its operational capabilities through strategic expansion.

To take advantage of the opportunities, the analyst recommends the microbial fermentation technology companies to focus on precision fermentation systems for scalable beverage manufacturing, focus on industrial partnerships to scale functional food and feed ingredients, focus on pilot-scale infrastructure to bridge innovation and commercialization, focus on bio-based chemical platforms through technology collaboration, focus on medical and biopharmaceutical fermentation platforms, focus on direct and regionalized distribution channels, focus on value-linked and segmented pricing models, focus on credibility-led technical promotion, focus on application-driven and account-based promotion, focus on scalable food and feed fermentation solutions, focus on industrial bio-based chemical and enzyme applications.

This product will be delivered within 3-5 business days.